Reclassification of Active Products without Intended Medical Purpose in the European Union
The Commission published the Implementing Regulation (EU) 2022/2347, laying down rules for the reclassification of several active products without an intended medical purpose mentioned in MDR annex XVI. 

Active devices are classified according to MDR by the classification rules 9, 10, 11, 12 and 13. However, the rules 9 and 10 are applicable only to devices with an intended medical purpose and cannot be applied to active products without a medical purpose, specified in MDR annex XVI. Therefore, such products were classified as class I (according with rule 13) and had to demonstrate conformity with relatively less requirements than analogous devices with a medical purpose. 

Certain Member States requested the reclassification of several active products without an intended medical purpose to ensure an appropriate conformity assessment consistent with their inherent risks. 

Implementing Regulation (EU) 2022/2347 

On 2 December 2022, the Commission published the Implementing Regulation (EU) 2022/2347 in the Official Journal of the European Union, laying down rules for the reclassification of these products.  

The following groups of active products without an intended medical purpose listed in MDR Annex XVI are reclassified as follows:  

Section of annex XVI Product Previous classification Updated classification 
Section 4 Equipment intended to be used to reduce, remove or destroy adipose tissue.  Ex.: Equipment for liposuction, radiofrequency lipolysis, ultrasound lipolysis, cryolipolyisis, laser lipolysis, infrared and electrical stimulation lipolysis, acoustic shockwave therapy or lipoplasty Class I Class IIb 
Section 5 Equipment emitting high intensity electromagnetic radiation intended for hair removal.  Ex.: Lasers and intense pulsed light equipment Class I Class IIa 
Section 5 Equipment emitting high intensity electromagnetic radiation intended for skin treatment, skin resurfacing, scar removal, tattoo removal, or for treatment of nevi flammei, haemangioma, telangiectasia and pigmented skin areas.  Ex.: Lasers and intense pulsed light equipment Class I Class IIb 
Section 6 Equipment intended for brain stimulation that apply electrical currents or magnetic or electromagnetic fields that penetrate the cranium to modify neuronal activity in the brain.  Ex.: Equipment for transcranial magnetic stimulation or transcranial electric stimulation Class I Class III 

The Implementing Regulation (EU) 2022/2347 enters into force on 22 December 2022, is binding in its entirety and directly applicable in all Member States. 

For more information feel free to contact us at info@criticalcatalyst.com.

References:

Implementing Regulation (EU) 2022/2347

further
reading

cosmetic products

P-Cymene may soon be banned from cosmetics

Ingredient: P-CYMENE

Date of publication: 10/1/2025

P-cymene may be banned from cosmetics as its proposed classification as Reprotoxic 1B is under review and is expected to be approved.

Read More »
cosmetic products

SCCS Preliminary Opinion on Benzophenone-1 (BP-1)

Ingredient: BENZOPHENONE-1

Date of publication: 25/10/2024

On October 25 2024, the Scientific Committee on Consumer Safety (SCCS) could not conclude on the safety of UV absorber Benzophenone-1 (BP-1) due to insufficient data. The deadline for comments is set to January 13, 2025.

Read More »
cosmetic products

UK – OPSS Releases Statuatory Instrument on CMR Substances and Kojic Acid

Ingredients: CMR SUBSTANCES AND KOJIC ACID

Date of publication: 17/12/2024

On December 17, 2024, UK’s Office for Product Safety and Standards (OPSS) published the Cosmetic Products (Restriction of Chemical Substances) (No.2) Regulations 2024′ adding 64 substances classified as Carcinogenic, Mutagenic, or Reprotoxic (CMR) to Annex II of the UK Cosmetics Regulation (UKCR) and Kojic Acid to Annex III of the UKCR.

Read More »
cosmetic products

SCCS Preliminary Opinion on Ethylhexyl Methoxycinnamate (EHMC)

Ingredient: ETHYLHEXYL METHOXYCINNAMATE (EHMC)

Date of publication: 25/10/2024

On October 25 2024, the Scientific Committee on Consumer Safety (SCCS) could not conclude on the safety of UV-filter Ethylhexyl Methocycinnamate (EHMC) due to insufficient data. The deadline for comments is set to January 17, 2025.

Read More »